New NPS MedicineWise case study focuses on type 2 diabetes

The latest NPS MedicineWise case study Type 2 diabetes: tailoring ongoing treatment has been launched in a new dynamic online format. The case study focuses on available treatment options for a 75-year-old male with type 2 diabetes and offers continuing professional development (CPD) points for GPs, pharmacists and nurses.

NPS MedicineWise clinical adviser Dr Andrew Boyden says the new online case study offers an interactive, engaging and flexible online learning experience.

“The case study provides immediate individual and peer results to challenge thinking and includes feedback from an expert in the field of diabetes: Professor Stephen Twigg from the University of Sydney,” he says.

“Diabetes is one of the most prevalent chronic conditions in Australia and 1 in 4 people over the age of 75 are estimated to have type 2 diabetes, so this case study is an essential learning activity for all health professionals.”

Participants are able to work through the clinical scenario online with interactive questions and receive immediate feedback based on their responses. The activity also provides best practice points that can be applied to patient care.

“Users are able to access the case study on a computer or tablet and switch between devices seamlessly meaning you can start the learning activity at the workplace and continue it on the train on the way home,” says Dr Boyden.

The case study covers concepts including:

  • Management of CVD risk factors and glycaemic control
  • Update on role of low-dose aspirin for patients with type 2 diabetes
  • Changes to HbA1c reporting
  • Advantages and disadvantages of newer glucose lowering medicines
  • Tailoring treatment for an older patient with type 2 diabetes

Case studies are also recognised for the Quality Prescribing Incentive (QPI) of the Practice Incentives Program (PIP). This activity is also accredited for pharmacists and nurses to earn CPD credits.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New therapy from UI Health becomes the first FDA-approved treatment for brittle type 1 diabetes